JAPMA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Norris, D. M.
Right arrow Articles by Werber, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Norris, D. M.
Right arrow Articles by Werber, B. R.
Journal of the American Podiatric Medical Association
Volume 95 Number 6 517-524 2005
Copyright © 2005 American Podiatric Medical Association

Effectiveness of Extracorporeal Shockwave Treatment in 353 Patients with Chronic Plantar Fasciitis

Donald M. Norris, MD *, Kimberly M. Eickmeier, DPM {dagger} and Bruce R. Werber, DPM {ddagger}

* United Shockwave Therapies, Des Plaines, IL.
{dagger} Department of Podiatric Surgery and Medicine, Christie Clinic PC, Champaign, IL.
{ddagger} Instep Foot & Ankle Specialists, Warwick, RI.

Corresponding author: Kimberly M. Eickmeier, DPM, Department of Podiatric Surgery and Medicine, Christie Clinic PC, 1801 W Windsor Rd, Champaign, IL 61821.

Abstract

A 16-question post-treatment survey was sent to 874 patients after extracorporeal shockwave treatment for chronic plantar fasciitis. Of the 377 surveys returned, 353 were used for analysis. These patients were treated by 169 physicians in 19 states using either electrohydraulic or electromagnetic extracorporeal shockwave equipment. Seventy-six percent of the patients underwent treatment after having had continued pain for a year or longer. Seventy percent of patients who rated their pretreatment pain level as severe (score ≥ 8 on a scale from 1 to 10) experienced sharp declines in pain, with a sharp decline considered to be a difference in pain level before and after treatment of 3 or more. In addition, 66% of patients who rated their pretreatment immobility as severe (score ≥ 8 on a scale from 1 to 10) experienced sharp declines in immobility. Of the patients who underwent extracorporeal shockwave treatment, 69% indicated that they would recommend this procedure to someone in a similar situation. If extracorporeal shockwave treatment were not available, 62% of patients indicated that they would have undergone open or invasive surgery, and 41% indicated that they would have continued with additional physician office visits. (J Am Podiatr Med Assoc 95(6): 517–524, 2005)






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Podiatric Medical Association.